Advanced Biomed ADVB Cash Flow Statement (2023-2026)

NASDAQ ADVB
$9.50 +0.26 (+2.81%)
As of: Aug 27, 2026 · 3:59 PM EDT
Reported Financials

Advanced Biomed Quarterly Cash Flow Statement

Periods 10 quarters
Latest Mar 2026

Advanced Biomed reported cash from operations of -$0.24M and free cash flow of -$0.24M for the quarter ended Mar 2026, up 95.2% year over year. This cash flow statement covers 10 quarters of results from Dec 2023 through Mar 2026, standardized by Business Quant from the company’s SEC filings.

Cash Flow Statement Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Operating Activities
Net Income -0.15M-1.06M-0.81M-0.27M-0.91M-1.38M-1.50M-0.39M6.86M-0.49M
Cash from Discontinued Operations 2.03M
Cash from Operations -1.07M-0.48M-0.03M-0.84M-5.04M0.09M-0.61M-0.51M-0.24M
Depreciation, Depletion & Amortization
Depreciation & Amortization (CF)Depreciation & Amortization 0.08M0.15M0.10M-0.06M0.02M0.28M0.05M-0.01M0.01M
Change in Working Capital
Change in Accured Expenses -0.08M0.18M0.17M-0.13M-2.21M2.06M-0.23M-0.10M0.04M
Other Working Capital Changes 0.01M0.01M0.04M-0.04M2.04M0.64M0.06M-0.71M-0.20M
Investing Activities
Capital Expenditures -0.09M0.12M0.02M-0.01M0.00M0.07M-0.01M0.02M0.00M
Cash from Investing Activities 0.03M-0.05M-0.02M0.01M-0.00M-0.02M-0.00M-0.01M-0.00M
Financing Activities
Other financing activities -0.02M0.35M0.00M5.16M6.56M-5.92M
Debt Issuance and Repayment
Long-Term Debt Issuances 0.76M0.34M0.21M0.30M0.05M0.22M0.45M-0.31M0.00M
Change in Capital Stock
Net Equity Issued and Repurchased 0.20M
Misc.
Cash from Financing Activities 0.56M0.32M0.39M0.41M5.90M-0.77M0.45M0.32M0.27M
Exchange Rate Effect 0.36M0.15M-0.30M0.37M0.07M0.08M-0.08M0.29M
Change in Cash -0.11M-0.06M0.04M0.01M2.53M-2.28M-0.25M-0.05M-0.00M
Free Cash Flow -0.97M-0.60M-0.05M-0.83M-5.04M0.02M-0.60M-0.54M-0.24M
Net Cash Flow -0.48M-0.21M0.34M-0.42M0.86M-0.70M-0.16M-0.21M0.03M